Engineers Gate Manager’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.2M | Buy |
56,716
+33,456
| +144% | +$2.18M | 0.04% | 534 |
|
|
2025
Q4 | $1.86M | Sell |
23,260
-81,579
| -78% | -$5.48M | 0.02% | 741 |
|
|
2025
Q3 | $5.11M | Buy |
104,839
+94,076
| +874% | +$5.82M | 0.06% | 391 |
|
|
2025
Q2 | $803K | Sell |
10,763
-14,890
| -58% | -$986K | 0.01% | 1230 |
|
|
2025
Q1 | $1.63M | Buy |
25,653
+22,953
| +850% | +$1.56M | 0.03% | 789 |
|
|
2024
Q4 | $211K | Sell |
2,700
-26,154
| -91% | -$2.1M | ﹤0.01% | 1870 |
|
|
2024
Q3 | $2.32M | Sell |
28,854
-13,304
| -32% | -$1.07M | 0.05% | 591 |
|
|
2024
Q2 | $3.49M | Sell |
42,158
-47,242
| -53% | -$4.16M | 0.08% | 360 |
|
|
2024
Q1 | $7.63M | Buy |
89,400
+81,019
| +967% | +$6.36M | 0.2% | 116 |
|
|
2023
Q4 | $717K | Buy |
8,381
+1,389
| +20% | +$120K | 0.02% | 986 |
|
|
2023
Q3 | $626K | Buy |
6,992
+723
| +12% | +$64.6K | 0.02% | 952 |
|
|
2023
Q2 | $534K | Buy |
6,269
+714
| +13% | +$60.4K | 0.02% | 1016 |
|
|
2023
Q1 | $460K | Sell |
5,555
-7,829
| -58% | -$634K | 0.02% | 1014 |
|
|
2022
Q4 | $1.05M | Buy |
+13,384
| New | +$1.08M | 0.06% | 445 |
|
|
2022
Q1 | – | Sell |
-41,522
| Closed | -$2.2M | – | 2030 |
|
|
2021
Q4 | $2.2M | Buy |
+41,522
| New | +$2.53M | 0.1% | 251 |
|
|
2021
Q3 | – | Sell |
-27,709
| Closed | -$1.85M | – | 1772 |
|
|
2021
Q2 | $1.85M | Buy |
27,709
+13,350
| +93% | +$945K | 0.12% | 198 |
|
|
2021
Q1 | $1.59M | Buy |
14,359
+11,364
| +379% | +$1.41M | 0.08% | 366 |
|
|
2020
Q4 | $356K | Sell |
2,995
-3,896
| -57% | -$419K | 0.02% | 1187 |
|
|
2020
Q3 | $601K | Sell |
6,891
-14,551
| -68% | -$1.27M | 0.03% | 888 |
|
|
2020
Q2 | $1.92M | Buy |
21,442
+14,823
| +224% | +$1.5M | 0.1% | 303 |
|
|
2020
Q1 | $660K | Sell |
6,619
-21,265
| -76% | -$2.31M | 0.05% | 624 |
|
|
2019
Q4 | $3.2M | Buy |
27,884
+25,232
| +951% | +$3.05M | 0.14% | 196 |
|
|
2019
Q3 | $335K | Buy |
+2,652
| New | +$337K | 0.02% | 961 |
|
|
2019
Q2 | – | Sell |
-4,800
| Closed | -$420K | – | 1235 |
|
|
2019
Q1 | $420K | Buy |
+4,800
| New | +$437K | 0.03% | 650 |
|
|
2018
Q1 | – | Sell |
-21,528
| Closed | -$1.25M | – | 861 |
|
|
2017
Q4 | $1.25M | Buy |
+21,528
| New | +$1.13M | 0.09% | 416 |
|
|
2015
Q3 | – | Sell |
-14,683
| Closed | -$607K | – | 778 |
|
|
2015
Q2 | $607K | Buy |
+14,683
| New | +$619K | 0.06% | 558 |
|
Other funds holding HAE
VPM
VCM
RRAM
Engineers Gate Manager's HAE Position: Q1 2026 in Review
Engineers Gate Manager increased its Haemonetics (HAE) stake by 144% in Q1 2026, buying an estimated $2.18M and bringing the position to 56,716 shares worth $3.2M. The position accounts for 0.04% of the portfolio, ranked #534.
Engineers Gate Manager first reported a position in HAE in Q2 2015 and has held it in 26 quarters since. The position peaked at $7.63M in Q1 2024. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.
- Engineers Gate Manager held 56,716 shares of Haemonetics worth $3.2M as of Q1 2026.
- Engineers Gate Manager bought 33,456 Haemonetics shares in Q1 2026, an estimated $2.18M.
- Haemonetics made up 0.04% of Engineers Gate Manager's portfolio in Q1 2026, its #534 holding.
- Engineers Gate Manager first reported a position in Haemonetics in Q2 2015 and has held it in 26 quarters since.
- Engineers Gate Manager's Haemonetics position peaked at $7.63M in Q1 2024.
- 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.
Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.